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TO THE EDITOR
Kindler syndrome (KS) (OMIM 173650)
is a rare autosomal recessive genoder-
matosis characterized by trauma-in-
duced blistering, poikiloderma, and
varying degrees of photosensitivity
(Kindler 1954). Over 50 cases of KS
have been reported although clinical
heterogeneity is well recognized (Ash-
ton et al., 2004). The gene responsible
for KS, KIND1, encodes a 677-amino-
acid protein called kindlin-1 (pre-
viously also known as kindlerin), which
is involved in linking the actin cytoske-
leton to focal contacts (Jobard et al.,
2003; Siegel et al., 2003). Loss of
kindlin-1 in keratinocytes has recently
been shown to lead to decreased cell
adhesion, reduced proliferation, in-
creased apoptosis, and loss of cell
polarity (Herz et al., 2006). KS therefore
represents the first inherited skin dis-
order to result from primary defects in
the actin cytoskeleton/focal contacts
and, thus far, 25 different mutations in
KIND1 in individuals with KS have
been published, most of which lead to
loss of KIND1 mRNA and kindlin-1
protein expression (Jobard et al., 2003;
Siegel et al., 2003; Ashton et al., 2004;
Has and Bruckner-Tuderman (2004);
Fassihi et al., 2005; Sethuraman et al.,
2005; Thomson et al., 2006; Has
et al., 2006; Burch et al., 2006; Sadler
et al., 2006). Collectively, however,
these mutations do not readily explain
the clinical heterogeneity seen in KS
and a paradigm for genotype–pheno-
type correlation is still lacking. In this
report, therefore, we describe five new
homozygous mutations in individuals
with KS and assess these and the
previously published KIND1 mutations
to explore further the clinical implica-
tions of determining KIND1 mutations
in this unusual genodermatosis.
Case 1 is a 15-year-old Indian male
born to consanguineous parents (Figure
1a–c). He developed recurrent episodes
of generalized blistering, which later
became confined to his hands and feet.
He also suffered from photosensitivity
with marked poikiloderma of sun-ex-
posed areas beginning at 5 years of age.
His skin was atrophic particularly on
the dorsal aspect of the hands and feet.
His palmoplantar skin showed diffuse
waxy thickening and his nails were
dystrophic. In addition, he had chronic
gingivitis and urethral stenosis. His 12-
year-old sister had similar skin and oral
abnormalities (Figure 1d).
Case 2 is a 30-year-old Indian male
born to consanguineous parents (unre-
lated to case 1). He developed acral
blisters during infancy and followed by
progressive skin atrophy with poikilo-
derma. He developed photosensitivity
from the age of 8 years and suffered
with gingival bleeding, which improved
in adulthood. He also suffered from
dysphagia and urethral stenosis but had
no nail dystrophy.
Case 3 is a 30-year-old Somalian
male born to consanguineous parents.
His clinical features consisted of acral
blistering in childhood and generalized
but mild ichthyosis. He also had acral
keratoses, fused web spaces and suf-
fered from photosensitivity since early
childhood. Further, he had small ero-
sions scattered on his trunk and ex-
tremities and his gingival mucosa bled
easily. One of his brothers, now de-
ceased, had similar clinical features.
Case 4 is a 15-year-old South African
male of Indian ancestry born to non-
consanguineous but geographically
linked parents. He had a single self-
limiting episode of blistering on his left
heel at birth. Thereafter, he developed
progressive and marked skin atrophy on
the dorsae of his hands and feet with
occasional fissuring. Poikiloderma af-
fecting the face, arms and legs was
evident. He developed photosensitivity
that started in infancy but which
improved in adolescence. In addition,
he had chronic gingivitis since child-
hood, which was associated with easily
bleeding gums and marked dental
caries. There were no other mucosal
disease or nail abnormalities.
Case 5 is a 3-year-old Indian female
born to consanguineous parents (not
related to case 1 or 2). She developed
acral blistering 10 days after birth. Her
skin was atrophic, especially on the
dorsal aspects of her hands and feet.
She had progressive poikiloderma,
which started at the age of 1 year and
affected her neck, face, and extremities.
She suffered with easily bleeding gums
and rectum (related to anal fissure).
Nails were normal.
Blood sampling and KIND1 gene
analysis were performed following ethi-
cal committee approval from Guy’s
and St Thomas’ Hospital. Written in-
formed consent was obtained from
each individual patient and the study
was conducted according to Declara-
tion of Helsinki Principles. PCR ampli-
fication of genomic DNA was carried
out using 14 pairs of primers spanning
the coding exons and flanking introns of
the KIND1 gene, as described else-
where (Siegel et al., 2003; Ashton et al.,
2004). The PCR products were purified
using a QIAquick PCR purification kit
(Qiagen, Crawley, UK) and sequenced
in an ABI 310 genetic analyzer (Applied
Biosystems, Warrington, UK).
Each subject with KS was homozy-
gous for a novel single nucleotide
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substitution in KIND1 (Figure 2a), result-
ing in either a nonsense mutation (cases
1, 4, and 5) or a splice site mutation
(cases 2 and 3). The mutations comprised
case 1 p.E168X, case 2 IVS13þ1G4A,
case 3 IVS14-1G4C, case 4 p.S114X,
and case 5 p.E516X. None of these
mutations was identified in screening
100 ethnically matched control chromo-
somes. When added to previous mole-
cular studies in KS, 30 different
pathogenic mutations in KIND1 have
been documented. These consist of 12
nonsense, 11 frameshift, six splice site
mutations, and one Alu/Alu recombina-
tion-associated internal deletion. Of
these, nine mutations have been reported
in more than one family, either as
propagated ancestral alleles (IVS7-
1G4A, p.E304X, p.W616X, c.1161delA,
g.70250_74168del, c.373delT) or as
recurrent mutations in diverse ethnic
groups (c.676insC, p.R271X, p.R288X)
(Ashton et al., 2004; Has et al., 2006).
Each of the new homozygous muta-
tions we identified is predicted to
produce a truncated kindlin-1 protein
and/or low levels of mRNA expression.
Clinically, however, there does not
appear to be any clear correlation
between the site or nature of the muta-
tions and the specific features of the
disease. In these five individuals with KS,
there was considerable variability in
clinical features such as presence or
absence of urethral involvement or
dysphagia or nail dystrophy as well as
the degree of photosensitivity, the onset
of the poikiloderma, or the extent of the
gingival fragility. These differences may
partly be explained by the different ages
at which the cases were assessed be-
cause many of the clinical features or
complications of KS only manifest with
time. In addition, the diverse ethnic and
geographical backgrounds of the cases
studied may also have an impact on
a b
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Figure 1. Clinical features of KS in a 15-year-old Indian male (a–c) and his similarly affected 12-year-old
sister (d), both homozygous for the mutation p.E168X in KIND1. (a) Marked poikiloderma is present
across the neck and upper trunk; (b) there is pseudo-syndactyly of the fingers and toes as well as extensive
poikiloderma on the limbs; (c) scarring on the glans penis leading to stenosis and obliteration of the
urethral meatus; (d) extensive erosive gingivitis.
Figure 2. New mutations in KIND1 and the spectrum of pathogenic mutations in Kindler syndrome. (a) In case 1, there is a homozygous G4T transversion at
nucleotide c.502 changing a glutamic acid codon (GAG) to a stop codon (TAG), designated p.E168X. In case 2, there is homozygous donor splice site mutation
within intron 13, IVS13þ1G4A. In case 3, there is a homozygous acceptor splice site mutation within intron 14, IVS14-1G4C. In case 4, there is a
homozygous C4G transversion at nucleotide c.341, converting a serine residue (TCA) to a stop codon (TGA), designated p.S114X. In case 5, there is a
homozygous G4T transversion at nucleotide c.1546 causing replacement of a glutamic acid (GAG) codon by a stop codon (TAA), designated p.E516X.
(b) The current database of KIND1 mutations is shown, including the five new mutations identified in this study (highlighted in purple text).
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phenotype. Moreover, review of the
published mutation reports in KS demon-
strates widespread clinical heterogeneity
even for individuals with identical
KIND1 mutations and the same ethni-
city. For example, the homozygous
mutation c.676insC, which has been
reported in 11 individuals from seven
families of Pakistani origin (with either
similar or different KIND1 haplotypes),
has been associated with poikiloderma
and blistering in all subjects but with
varying degrees of chronic gingivitis and
skin atrophy (Ashton et al., 2004; Thom-
son et al., 2006). Likewise, intra- and
interfamilial heterogeneity in the KS
phenotype is also evident for the recur-
rent homozygous KIND1 mutations
p.E304X and p.R271X. In some cases,
environmental factors such as the degree
of sun exposure or oral trauma might
account for some of the phenotypic
diversity. For example, individuals from
Panama and Oman who are homozy-
gous for the mutation p.R271X tend to
have an earlier onset of photosensitivity
and poikiloderma compared with sub-
jects from the USA harboring the same
homozygous nonsense mutation in
KIND1 (Siegel et al., 2003; Penagos
et al., 2004). Moreover, these Panama-
nian cases with KS usually have less
gingival inflammation in early life, which
may reflect a relatively later introduction
of a solid diet. Another variable clinical
feature is squamous cell carcinoma
which has been described in four cases
of KS (Lotem et al., 2001; Ashton et al.,
2004; Has et al., 2006; Emanuel et al.,
2006), two of whom had known KIND1
mutations (Ashton et al., 2004; Has
et al., 2006). The squamous cell carci-
nomas developed between the ages of
34 and 57 years but as most of the
KIND1 mutation database involves in-
dividuals younger than this (including
the five cases in our report) there is
currently insufficient data to correlate
KIND1 mutations with the risk of muco-
cutaneous malignancy in KS.
In summary, analysis of the clinical
features present in our new cases of KS
and the previously published reports
reveal that blistering, poikiloderma,
photosensitivity, skin atrophy, and peri-
odontal inflammation are common fea-
tures but there are no obvious phenotypic
differences resulting from the various
nonsense, frameshift, deletion, or splice
site mutations in KIND1. As far as genetic
counseling is concerned, delineation of
pathogenic mutations in KIND1 is very
useful in making an early diagnosis of KS
(Fassihi et al., 2005), but, unlike muta-
tional analysis in other blistering geno-
dermatoses such as dystrophic
epidermolysis bullosa that results from
mutations in the COL7A1 gene, the
nature of the KIND1 mutations in KS
does not have much value in predicting
the clinical course and potential compli-
cations of the disease. Other environ-
mental exposures as well as currently
unknown genetic or epigenetic factors
may have a significant impact on pheno-
typic expression in KS.
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